Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | RAC2 | P15153 | 1/20 | 0.33 |
| ▸ | RAC3 | P60763 | 1/20 | 0.33 |
| ▸ | CDC42 | P60953 | 1/20 | 0.33 |
| ▸ | RAC1 | P63000 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.31 |
| ▸ | ICMT | O60725 | 1/20 | 0.31 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19269547 | 0.91 | ATM (0.38) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL19269494 | 0.91 | ATM (0.37) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL19269847 | 0.89 | ATM (0.36) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL19269536 | 0.88 | ATM (0.41) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL19269825 | 0.88 | ATM (0.41) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL10315675 | 0.88 | ATM (0.45) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL10315692 | 0.88 | ATM (0.45) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL14119376 | 0.88 | ATM (0.45) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL10315676 | 0.88 | ATM (0.45) | ATMKDM4EL3MBTL1RAC2RAC3 | |
| SCHEMBL19270099 | 0.87 | ATM (0.41) | ATMKDM4EL3MBTL1TSPOICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180212158-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-07-26 | — | — | US | disclosed |
| US-20180212158-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-07-26 | — | — | US | disclosed |
| US-20170244049-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180212158-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | MSN, DDT, NECTIN4 | ATM 3591/4885KDM4E 2444/4885L3MBTL1 206/4885 |
| US-20170244049-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | CYBA, DDT, DRD1 | ATM 1981/4885KDM4E 2858/4885L3MBTL1 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.